James Linder height - How tall is James Linder?

Linder has been accorded several professional honors and awards. In 2015, recognizing accomplishments in laboratory medicine and technology transfer, he was inducted as a fellow of the National Academy of Inventors. In 2014 he and Karen Linder received the Entrepreneurial Leadership Award. In 2013 Linseed Capital was recognized as Investor of the Year by the Silicon Prairie News. In 2005, he was presented with the American Society of Clinical Pathologists' "Israel Davidsohn Award for Distinguished Service."

Linder served as interim president of the University of Nebraska system from May 2014 until April 2015. He has served on the UNMC faculty since 1983 when he joined the Pathology and Microbiology department. In 1986 he was named associate professor and in 1989 was named professor. He has held numerous administrative positions at UNMC, including vice chairman of Pathology and Microbiology, director of Surgical Pathology, director of Cytopathology, associate dean for Academic Affairs and interim dean of Medicine. He was associate vice chancellor for Research from 2005-2009, and was responsible for developing clinical research and intellectual property programs at UNMC. He also served as visiting professor at the Peter Kiewit Institute. In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.

From 2009-13, he was founding chief medical officer for Constitution Medical Investors. The company was later acquired by the Roche Diagnostics in 2013, and Linder stayed on until 2015 and developed a hematology analyzer. where he served as a Chief Medical Officer,

From 1999-2001, he served on the board of directors of the Omaha Children's Museum. He has served as chairman of the board of KANEKO, an organization devoted to fostering creativity, and serves as chair of the Kaneko Creative Council. He was a regional board member of the Pipeline Entrepreneurship Program.

From 1995 to 2007 he served as medical director of Cytyc Corporation, a company based in Marlborough, Mass. dedicated to women's health. A main area of interest was improving Pap testing.

A native to Omaha, Linder earned his B.S. degree in biochemistry and microbiology from Iowa State University in 1976, and his M.D. degree, with distinction, from the University of Nebraska Medical Center (UNMC) in 1980. He completed his residency training in pathology at Duke University Medical Center and UNMC.

James "Jim" Linder (born 1954) is an American author, academic and business leader, and is an authority on university research commercialization. He serves as chief executive officer (CEO) of Nebraska Medicine, and most recently was president of the University Technology Development Corporation and chief strategist for the University of Nebraska system. He is also a professor of pathology and microbiology at the University of Nebraska Medical Center.